Search
Tiopinac
go.drugbank.com/drugs/DB19642ExperimentalTiopinac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Tiopinac is a anti-inflammatory agent, ibufenac derivative. … Tiopinac has a monoisotopic molecular weight of 284.05 Da.
Pirazolac
go.drugbank.com/drugs/DB20690ExperimentalPirazolac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Pirazolac is a anti-inflammatory agent, ibufenac derivative. … Pirazolac has a monoisotopic molecular weight of 330.06 Da.
Imitrodast
go.drugbank.com/drugs/DB20840ExperimentalImitrodast is a small molecule drug. The usage of the INN stem '-trodast' in the name indicates that Imitrodast is a antiasthmatic thromboxane A2-receptor antagonist. … Imitrodast has a monoisotopic molecular weight of 260.06 Da.
Tianafac
go.drugbank.com/drugs/DB21045ExperimentalTianafac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Tianafac is a anti-inflammatory agent, ibufenac derivative. … Tianafac has a monoisotopic molecular weight of 240.0 Da.
Fenclofenac
go.drugbank.com/drugs/DB21391ExperimentalFenclofenac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Fenclofenac is a anti-inflammatory agent, ibufenac derivative. … Fenclofenac has a monoisotopic molecular weight of 296.0 Da.
Tifurac
go.drugbank.com/drugs/DB21415ExperimentalTifurac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Tifurac is a anti-inflammatory agent, ibufenac derivative. … Tifurac has a monoisotopic molecular weight of 326.06 Da.
Malathion
go.drugbank.com/drugs/DB00772ApprovedMalathion is a parasympathomimetic organophosphate compound that is used as an insecticide for the treatment of head lice. … Malathion is an irreversible cholinesterase inhibitor and has low human toxicity.
Categories: Compounds used in a research, industrial, or household settingProducts: A-FLEAZ SHAMPOO 1% w/wPF-5212372
go.drugbank.com/drugs/DB19212InvestigationalPF-5212372 is under investigation in clinical trial NCT02795832 (A Study to Determine the Safety & Efficacy of ZPL-5212372 in Healthy Subjects and in Subjects With Atopic Dermatitis).
Categories: Phospholipase A2 InhibitorsSapropterin
go.drugbank.com/drugs/DB00360ApprovedInvestigationalSapropterin (tetrahydrobiopterin or BH4) is a cofactor in the synthesis of nitric oxide.
Nirogacestat
go.drugbank.com/drugs/DB12005ApprovedInvestigationalNirogacestat is a small-molecule gamma-secretase inhibitor that was investigated as a potential treatment for desmoid tumors. … granted breakthrough therapy, fast track, and orphan drug designations for the treatment of desmoid tumors, and the final approval was based on positive results obtained in the Phase 3 DeFi trial, where a